Medispar
ActiveSummary
The computed 12-month bankruptcy probability of Medispar is 1.9% (moderate). The annual accounts of Medispar for financial year 2025 show a net loss of 498% of the equity at the start of that year. The 2025 annual accounts show equity of €471,959 and a net result of -€1.2m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 28% of 5,027 sector peers (NACE 47, financial year 2025). The company has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Wijziging, Artikel 12” (deed in Dutch)deed of 14-11-2025
- Other provisionsOther rules from the articles that fall under none of the themes above.
- 1 more provision in the deed, see the deed of 30-12-2022
Read from the deeds: 2 provisions, deed of 14-11-2025